Market Overview:
The global breast cancer imaging diagnostic equipment market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of breast cancer, technological advancements in imaging diagnostic equipment, and rising demand for early diagnosis and treatment of breast cancer. Based on type, the global market for breast cancer imaging diagnostic equipment is segmented into X-ray equipment, computed tomography (CT) equipment, magnetic resonance (MR) equipment, and ultrasonic (US) equipment. Of these segments, X-ray Equipment held the largest share of the global market in 2017 owing to its low cost and easy availability. However, CT Equipment is projected to grow at the highest CAGR during the forecast period due its ability to provide high-resolution images with greater accuracy than other types of imaging diagnostic equipments. On basis application Hospital held majority revenue share followed by Clinic .
Product Definition:
The breast cancer imaging diagnostic equipment is a device used to diagnose breast cancer. It is important because it can help detect the disease at an early stage, when it is more likely to be cured.
X-ray Equipment:
X-ray equipment is a device that produces and receive images of body parts using radiation. The primary function of an X-ray machine is to diagnose, monitor, and treat diseases by producing radiations which are then absorbed by the body tissues. An average X-ray machine has the ability to produce 2 million effective doses each year with no risk to patients (more than 100 million total exposure in a career).
Computed Tomography Equipment:
Computed tomography equipment is a diagnostic medical device that helps in obtaining cross-sectional images of the targeted area. It works by ionizing the body tissues and then determining the density of those tissues. A computer receives this data and projects an image onto a screen, which can be viewed by doctors as well as patients.
Application Insights:
Based on application, the market is segmented into hospital, clinic and other. The hospital segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of breast cancer across various regions coupled with increasing awareness about early diagnosis among women aged 50 years and above. Breast imaging equipment is considered essential equipment at hospitals due to various advantages offered by these devices for diagnosing breast cancer including improved accuracy and sensitivity over film radiography.
The other application segment includes laboratories, imaging centers and others where diagnostic imaging equipment is used for non-invasive medical procedures or screening of patients without conducting invasive procedures such as biopsies or surgeries. Such applications require specialized knowledge regarding breast anatomy along with experience using these devices which are not available in every facility thus resulting in preference towards hospitals for diagnostic purposes related to this disease condition.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of technologically advanced products. Moreover, increasing cases of breast cancer are also expected to drive regional growth over the forecast period. Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving healthcare infrastructure and growing awareness about early diagnosis in emerging countries such as China and India. Furthermore, an increase in medical tourism due to better facilities for treatment is also driving demand for diagnostic equipment in this region. For instance, as per a WHO study published on 24 August 2018; around 1 million people from Japan travel overseas for medical reasons each year accounting it among top 10 destinations for medical tourism across globe (8).
Growth Factors:
- Increasing incidence of breast cancer
- Growing awareness about early detection of breast cancer
- Rising demand for minimally invasive diagnostic techniques
- Technological advancements in breast cancer imaging diagnostic equipment
- Growing number of private clinics and hospitals
Scope Of The Report
Report Attributes
Report Details
Report Title
Breast Cancer Imaging Diagnostic Equipment Market Research Report
By Type
X-ray Equipment, Computed Tomography Equipment, Magnetic Resonance Equipment, Ultrasonic Equipment
By Application
Hospital, Clinic, Other
By Companies
Siemens, Hologic, Philips, Fujifilm, Agfa-Gevaert Group, Mammotome, Aurora Healthcare US Corp, General Medical Merate Spa(IMS Giotto), Planmed Oy, KONICA MINOLTA, Carestream Health, Supersonic Imagine, Dilon Diagnostics, Allengers, Shantou Institute of Ultrasonic Instruments
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Breast Cancer Imaging Diagnostic Equipment Market Report Segments:
The global Breast Cancer Imaging Diagnostic Equipment market is segmented on the basis of:
Types
X-ray Equipment, Computed Tomography Equipment, Magnetic Resonance Equipment, Ultrasonic Equipment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- Hologic
- Philips
- Fujifilm
- Agfa-Gevaert Group
- Mammotome
- Aurora Healthcare US Corp
- General Medical Merate Spa(IMS Giotto)
- Planmed Oy
- KONICA MINOLTA
- Carestream Health
- Supersonic Imagine
- Dilon Diagnostics
- Allengers
- Shantou Institute of Ultrasonic Instruments
Highlights of The Breast Cancer Imaging Diagnostic Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- X-ray Equipment
- Computed Tomography Equipment
- Magnetic Resonance Equipment
- Ultrasonic Equipment
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Breast Cancer Imaging Diagnostic Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Breast cancer imaging diagnostic equipment is a type of medical equipment that is used to diagnose breast cancer. This includes devices that use X-rays, ultrasound, and magnetic resonance imaging (MRI) to image the breast.
Some of the key players operating in the breast cancer imaging diagnostic equipment market are Siemens, Hologic, Philips, Fujifilm, Agfa-Gevaert Group, Mammotome, Aurora Healthcare US Corp, General Medical Merate Spa(IMS Giotto), Planmed Oy, KONICA MINOLTA, Carestream Health, Supersonic Imagine, Dilon Diagnostics, Allengers, Shantou Institute of Ultrasonic Instruments.
The breast cancer imaging diagnostic equipment market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Breast Cancer Imaging Diagnostic Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Breast Cancer Imaging Diagnostic Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Breast Cancer Imaging Diagnostic Equipment Market - Supply Chain
4.5. Global Breast Cancer Imaging Diagnostic Equipment Market Forecast
4.5.1. Breast Cancer Imaging Diagnostic Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Breast Cancer Imaging Diagnostic Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Breast Cancer Imaging Diagnostic Equipment Market Absolute $ Opportunity
5. Global Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
5.3.1. X-ray Equipment
5.3.2. Computed Tomography Equipment
5.3.3. Magnetic Resonance Equipment
5.3.4. Ultrasonic Equipment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Breast Cancer Imaging Diagnostic Equipment Demand Share Forecast, 2019-2026
9. North America Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
9.7.1. X-ray Equipment
9.7.2. Computed Tomography Equipment
9.7.3. Magnetic Resonance Equipment
9.7.4. Ultrasonic Equipment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Breast Cancer Imaging Diagnostic Equipment Demand Share Forecast, 2019-2026
10. Latin America Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
10.7.1. X-ray Equipment
10.7.2. Computed Tomography Equipment
10.7.3. Magnetic Resonance Equipment
10.7.4. Ultrasonic Equipment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Breast Cancer Imaging Diagnostic Equipment Demand Share Forecast, 2019-2026
11. Europe Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
11.7.1. X-ray Equipment
11.7.. Computed Tomography Equipment
11.7.3. Magnetic Resonance Equipment
11.7.4. Ultrasonic Equipment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Breast Cancer Imaging Diagnostic Equipment Demand Share, 2019-2026
12. Asia Pacific Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
12.7.1. X-ray Equipment
12.7.2. Computed Tomography Equipment
12.7.3. Magnetic Resonance Equipment
12.7.4. Ultrasonic Equipment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Breast Cancer Imaging Diagnostic Equipment Demand Share, 2019-2026
13. Middle East & Africa Breast Cancer Imaging Diagnostic Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Breast Cancer Imaging Diagnostic Equipment Market Size and Volume Forecast by Type
13.7.1. X-ray Equipment
13.7.2. Computed Tomography Equipment
13.7.3. Magnetic Resonance Equipment
13.7.4. Ultrasonic Equipment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Breast Cancer Imaging Diagnostic Equipment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Breast Cancer Imaging Diagnostic Equipment Market: Market Share Analysis
14.2. Breast Cancer Imaging Diagnostic Equipment Distributors and Customers
14.3. Breast Cancer Imaging Diagnostic Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hologic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Philips
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fujifilm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agfa-Gevaert Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mammotome
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aurora Healthcare US Corp
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. General Medical Merate Spa(IMS Giotto)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Planmed Oy
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. KONICA MINOLTA
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Carestream Health
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Supersonic Imagine
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Dilon Diagnostics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Allengers
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Shantou Institute of Ultrasonic Instruments
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
